(SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule ...
Both of the Boston Marathon's defending wheelchair champions will return in April to race the 26.2 miles from Hopkinton to ...
As respiratory diseases enter a peak period in winter, multiple foreign media outlets have been exaggerating reports of a ...